Pharmaceutical Technology, Jan 1, 2006 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Pharmaceutical Technology, Jan 1, 2006
Pick a different issue
articles
Contract Manufacturers Gear Up For PAT
By George Koroneos
Contract manufactures are faced with multiple challenges when determining whether to implement process analytical technology into their clients' or their own infrastructure.
Essentials of Validation Project Management
By William Garvey
In the second half of this two-part series, the author suggests that to qualify and validate a pharmaceutical manufacturing facility, one must coordinate protocol and SOP development, scheduling and implementation, turnover package preparation, and the management and resolution of deviations and discrepancies. In combination with the programs described in Part I, these activities will help deliver projects on schedule, at estimated cost, and with quality assured.
Hypromellose, Ethylcellulose, and Polyethylene Oxide Use in Hot Melt Extrusion
By Karen A. Coppens , Mark J. Hall , Shawn A. Mitchell , Michael D. Read
Hot melt extrusion (HME) formulation development depends heavily on choosing the appropriate polymers. This article reviews HME process parameters and highlights three polymers in HME: polyethylene oxide, ethylcellulose, and hypromellose.
Zero-Tolerance Criteria Do Not Assure Product Quality
By John R. Murphy , Kristi L. Griffiths
The benefits of zero tolerance as a test criterion have been oversold. A critical examination of zero tolerance reveals that many of the supposed benefits are not attainable. More important, inappropriate application of this criterion can have a deleterious effect on the assessment, control, and improvement of the quality of pharmaceutical products.
Using the Bergum Method and MS Excel to Determine The Probability of Passing the USP Dissolution Test
By Pramote Cholayudth
Using the Bergum Method and the MS Excel software program, the author determines the probability of passing the USP dissolution test.
In the Field
January 2006
Merck (Whitehouse Station, NJ, www.merck.com) has revealed the "first phase" of its global restructuring program set to eliminate 7000 jobs (11% of its global workforce) by the end of 2008, close or sell 5 of its 31 manufacturing facilities, and roll out a manufacturing strategy to "drive significant efficiencies, decrease headcount, and reduce or refocus operations throughout the plant network and the entire manufacturing division." The company also expects to close one basic research site and two preclinical development sites.
Viewpoint
Incorporating Electronics in Drug Delivery
By Andrew Diston
It's time for the pharmaceutical industry to consider electronic innovations as part of their life cycle management strategies.
From The Editor
Empty Houses
By Douglas McCormick
Is the recent round of Big Pharma plant closings a sign of regrowth?
Agent-In-Place
Oil, Water, and Kicks
By Control, a senior compliance officer
A particular dermatological product was packaged in a metal tube, which is filled from the bottom.
Washington Report
Drug Development Prime Challenge for 2006
By Jill Wechsler
Manufacturers, FDA, and research organizations are collaborating on efforts to spur innovation and streamline drug production.
Outsourcing
Here's to a Strong 2006!
By Jim Miller
The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?
In the Spotlight
In the Spotlight
New tubing specifically designed for peristaltic pumps has been introduced by Maztech (Elkton, MD, www.smartshieldtubing.com).
This Time Around
Flu 2006 Spurs Paranoia and Innovation
By Kaylynn Chiarello-Ebner
It's impossible to watch the evening news without seeing an update about the robustness of this year's influenza strains and the potential threat of the avian flu. Given the staggering mortality rate (about 52%) among human avian flu victims, I can't help but straighten up and listen to the reports as a knot develops in my stomach.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is your main concern regarding the outsourcing of various services to emerging countries?
Safety and quality issues
Lack of regulation
Job losses in the West
The distance
I have no concerns
Safety and quality issues
47%
Lack of regulation
22%
Job losses in the West
13%
The distance
2%
I have no concerns
16%
View Results
Jim MillerOutsourcing OutlookJim Miller Be Careful for What You Wish
Patricia Van ArnumIngredients InsiderPatricia Van ArnumAugmenting Excipient Functionality
Faiz kermaniSpotlightFaiz Kermani Reducing the number of failures in early stage development
Faiz kermaniStatistical Solutions Lynn D. TorbeckOn the Verge of Significance: Why 5%?
FindPharma Custom Search
Click here